It's tough to write nuanced headlines, but a new study on AI in emergency rooms is getting way overhyped.

A second shot at gene therapy for Huntington's, China's tightening grip on pharma supply chains, and more Readout biotech ...

A rodent-borne illness is suspected of causing an outbreak aboard a cruise ship that has killed three people and sickened ...

Two drugmakers asked the U.S. Supreme Court to restore mail-order access to the abortion pill mifepristone, after an appeals ...

A federal appeals court on Friday ruled that mifepristone, known as the abortion pill, can be distributed only in person and ...

Latus Bio raised $42 million as it prepares to seek FDA approval to start a clinical trial for its gene therapy for ...

Labs are seeing fewer applications from international students and researchers, and some doctoral students are considering ...

China is now a peer competitor in drug innovation — and it intends to stay that way on its own terms, writes Dennis Kwok.

Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Katherine Szarama, who joined the FDA last year to serve as Vinay Prasad’s deputy, will now fill his shoes at CBER.

A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing ...